Skip to main content
WAY
NASDAQ Technology

Waystar 10-Q: Q3 Revenue $325.6M (+21%), Net Income $31.0M; NRR Slips to 107.6%

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$28.14
Mkt Cap
$5.396B
52W Low
$17.26
52W High
$38.095
52W Position info
63% above low
Off High info
26% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

WAY sits 63% above its 52-week low of $17.26.

Summary

Waystar's Q3 10-Q confirms 21% revenue growth to $325.6M and $31.0M of net income, while flagging a drop in net revenue retention to 107.6% and formally disclosing a June 2026 data breach affecting under 1% of clients.


Key Events · Earnings and Guidance · WAY

  • Q3 Revenue Up 21% to $325.6M

    Revenue rose to $325.6M from $268.7M, with subscription revenue up 34.4% to $180.7M; nine-month revenue was $959.2M, up 20.5%.

  • Net Income $31.0M, EPS $0.16

    Q3 net income was $31.0M ($0.16 diluted) versus $30.6M a year earlier; nine-month net income rose 25.1% to $115.2M.

  • Net Revenue Retention Slips to 107.6%

    NRR fell from 113.1% a year earlier, though clients generating over $100,000 rose to 1,488 from 1,306.

  • June 2026 Breach Disclosed

    Unauthorized acquisition of testing source code and four files of inactive data involved PHI/PII for fewer than 1% of clients; company says not material and expects partial insurance recovery.


Analysis · WAY · Technology

Two details in this 10-Q matter beyond the headline numbers already reported in the same-day earnings 8-K. First, net revenue retention fell to 107.6% from 113.1% a year earlier: growth is still coming from new clients and the Iodine acquisition, but existing customers are expanding more slowly. Second, the filing formally discloses a June 2026 breach in which source code used for testing and four files of inactive data were taken, touching PHI/PII for fewer than 1% of clients; management says it is not material and expects partial insurance recovery, but the ultimate cost is unknown. Buybacks are running well below the $200M authorization, with $166.6M left after $33.4M spent year-to-date.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, WAY was trading at $28.14 on NASDAQ in the Technology sector, with a market capitalization of approximately $5.4B. The 52-week trading range was $17.26 to $38.10. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

WAY - Latest Insights

WAY
Nov 02, 2026, 4:05 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $28.14
Real-time Price: $27.54 info
Change: -$0.600 (-2%) info
Market Cap: $5.298B info
WAY
Nov 02, 2026, 4:01 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $28.14
Real-time Price: $27.54 info
Change: -$0.600 (-2%) info
Market Cap: $5.298B info
WAY
Jul 29, 2026, 4:29 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $22.50
Real-time Price: $27.54 info
Change: +$5.04 (+22%) info
Market Cap: $5.298B info
WAY
Jul 29, 2026, 4:04 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $24.52
Real-time Price: $27.54 info
Change: +$3.02 (+12%) info
Market Cap: $5.298B info
WAY
Jul 29, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $22.44
Real-time Price: $27.54 info
Change: +$5.10 (+23%) info
Market Cap: $5.298B info